TotalAssist program - Patient Advocate Foundation

TotalAssist program - Patient Advocate Foundation
Skip to content
Introducing TotalAssist
Launching July 1, 2026, TotalAssist is a major step forward in how patient assistance works: simple, flexible, and centered on real-world patient needs.
What is TotalAssist?
How it supports patients
Putting patients first
Advancing health equity
List of TotalAssist funds
TotalAssist is the nation’s largest and most comprehensive charitable patient assistance portfolio
Starting July 1, 2026, Patient Advocate Foundation will launch TotalAssist—a unified financial assistance program designed to make it easier for patients to start and stay on treatment. By bringing together the strengths of Patient Advocate Foundation and PAN Foundation, TotalAssist is a major step forward in how patient assistance works: simple, flexible, and centered on real-world patient needs.
What is TotalAssist?
TotalAssist is the nation’s largest and most comprehensive charitable patient assistance portfolio. At launch, it will include over 130 disease-specific and health equity financial assistance funds, supporting patients across a wide range of conditions—from cancer and rare diseases to chronic and complex illnesses.
TotalAssist helps patients pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, office visit charges the day of treatment, and administration charges related to treatment. TotalAssist does not limit how grants can be used. Instead, TotalAssist allows patients to apply their grant toward multiple healthcare expenses, helping reduce gaps in care.
Through our TotalAssist program, patients may use grants for:
Medication copays, coinsurance, and deductibles
Health insurance premiums
Office visit charges the day of treatment
Administration charges related to treatment
This comprehensive approach reflects how patients actually experience care—and helps remove the financial barriers that too often interrupt treatment.
How it supports patients
At a time when healthcare costs continue to rise and more people are struggling to afford care, TotalAssist expands access, reduces complexity, and strengthens the safety net for patients nationwide.
Broad and reliable coverage
Over 130 disease-specific funds covering high-need conditions nationwide
Use of grants to cover more eligible out-of-pocket healthcare costs: medication copays, coinsurance, and deductibles, health insurance premiums, office visit charges the day of treatment, and administration charges related to treatment
Financial assistance for treatments that are FDA-approved, listed in official compendia, and published in evidence-based guidelines
Guaranteed grant amounts, with additional support provided automatically when available
Easier, faster access
No waitlists and first-come, first-served enrollment
Real-time fund notifications by email or text when funds open
Instant eligibility decisions at the time of application
Simplifying the patient journey
Simple online portals for patients, healthcare professionals, pharmacies, and nonprofits
Diagnosis verification handled directly with providers—reducing burden on patients
Streamlined medical claims, insurance premiums, and patient reimbursements: All processed in-house and can be easily uploaded via the portal
Point of sale pharmacy claims processing: Pharmacy claims are processed at the point of sale through a virtual pharmacy card, making it easy for both patients and pharmacies
Putting patients at the center
TotalAssist is designed to address patient realities and not add administrative complexity.
Key patient-focused features include:
Six-month lookback coverage, allowing eligible patients to apply assistance to qualifying expenses incurred before enrollment
Dedicated patient support specialists to guide patients and caregivers through enrollment
Concierge support to onboard and support providers and pharmacies
Patients also benefit from trusted tools like
FundFinder
, which helps identify alternative assistance when funds are unavailable, and the
National Financial Resource Directory
, which connects people to additional support beyond healthcare costs.
Get updates on our journey
Get updates on our journey
Sign up for announcements about our programs and initiatives, and reminders about the launch of TotalAssist. You’ll be the first to know when changes and new opportunities are on the horizon.
Advancing health equity
Patient Advocate Foundation pioneered
health equity funds
to ensure assistance reaches the people and communities who need it most. TotalAssist will include over 20 health equity funds, serving patients in hundreds of counties across dozens of states identified through a data-driven methodology using the CDC’s Social Vulnerability Index and disease incidence data.
Eligibility for health equity funds is determined by zip code, with all other requirements consistent with standard disease funds, helping reduce disparities while maintaining fairness and transparency.
TotalAssist Funds
Below is the list of funds that will be included at the TotalAssist launch on July 1, 2026.
As needs continue to evolve, the funds offered through TotalAssist will continue to grow, expanding support where gaps exist and ensuring assistance remains responsive to patients nationwide. When TotalAssist launches on July 1, 2026, fund eligibility may change with patient access in mind. We will continue to update this page and our
as information is released.
TotalAssist Funds (starting July 1, 2026)
A to L
M to Z
A-L
Fund name
Maximum award amount
Insurance type
Federal poverty level percentage
Acromegaly
$5,000
Government Insured
500
Acute Myeloid Leukemia (AML)
$8,600
Government Insured
500
Alzheimer’s Disease Health Equity
$3,500
Government Insured
500
Amyloidosis
$5,500
Government Insured
500
Asthma
$3,500
Government Insured
500
Asthma Health Equity
$3,500
Government Insured
500
Atopic Dermatitis
$4,200
Government Insured
500
Basal Cell Carcinoma
$4,600
All Insurances
500
Biliary Tract Cancer (BTC)
$6,200
Government Insured
500
Bipolar Disorder
$4,400
Government Insured
500
Bladder Cancer
$6,500
Government Insured
500
Breast Cancer
$6,500
All Insurances
500
Breast Cancer Health Equity
$6,500
All Insurances
500
Cancer Genetic and Genomic Testing
$250
All Insurances
500
Cervical Cancer
$4,000
All Insurances
500
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
$9,500
Government Insured
500
Chronic Kidney Disease (CKD)
$4,800
Government Insured
500
Chronic Lymphocytic Leukemia (CLL)
$9,500
All Insurances
500
Chronic Obstructive Pulmonary Disease (COPD)
$3,500
Government Insured
500
Chronic Obstructive Pulmonary Disease (COPD) Health Equity
$3,500
Government Insured
500
Chronic Spontaneous Urticaria (CSU)
$5,200
All Insurances
500
Colorectal Cancer
$5,000
Government Insured
500
Coronary Artery Disease (CAD) Health Equity
$1,500
Government Insured
500
COVID-19 & Post COVID
$2,300
All Insurances
500
Cushing’s disease or syndrome
$9,500
All Insurances
500
Cystic Fibrosis
$5,000
All Insurances
500
Diabetic Macular Edema (DME)
$4,500
Government Insured
500
Diabetic Retinopathy (DR)
$4,500
Government Insured
500
Diffuse Large B-cell Lymphoma (DLBCL)
$6,400
All Insurances
500
Duchenne Muscular Dystrophy (DMD)
$15,400
All Insurances
500
Eosinophilic Esophagitis
$2,000
Government Insured
500
Fabry Disease
$9,000
All Insurances
500
Fabry Disease Health Equity
$9,000
All Insurances
500
Follicular Lymphoma
$7,400
Government Insured
500
Gastrointestinal Stromal Tumors (GIST)
$4,200
Government Insured
500
Gaucher Disease
$14,000
All Insurances
500
Gaucher Disease Health Equity
$14,000
All Insurances
500
Glioblastoma Multiforme (GBM)
$3,800
All Insurances
500
Graft vs Host Disease (GvHD)
$9,500
All Insurances
500
Heart Failure
$2,500
Government Insured
500
Heart Failure Health Equity
$2,500
Government Insured
500
Hemolytic Uremic Syndrome (HUS)
$9,500
All Insurances
500
Hemophilia
$12,500
All Insurances
500
Hemophilia Health Equity
$12,500
All Insurances
500
Hepatitis B (HepB)
$3,000
All Insurances
500
Hepatitis B (HepB) Health Equity
$3,000
All Insurances
500
Hepatitis C (HepC)
$6,000
All Insurances
500
Hepatitis C (HepC) Health Equity
$6,000
All Insurances
500
HIV, AIDS, and Prevention
$5,000
All Insurances
500
HIV, AIDS, and Prevention Health Equity
$5,000
All Insurances
500
Hypercholesterolemia
$3,800
Government Insured
500
Hyperkalemia
$3,600
Government Insured
500
Hypophosphatasia
$9,500
All Insurances
500
Immune Thrombocytopenic Purpura (ITP)
$10,000
Government Insured
500
Inflammatory Bowel Disease (IBD)
$10,400
Government Insured
500
Inherited Retinal Disease (IRD)
$8,600
All Insurances
500
Lipodystrophy
$4,000
All Insurances
500
Liver Cancer
$7,600
Government Insured
500
Long-chain fatty acid oxidation disorders (LC-FAOD)
$11,800
All Insurances
500
Lysosomal Acid Lipase Deficiency (LAL-D)
$9,500
All Insurances
500
Lupus
$4,500
Government Insured
500
Lupus Health Equity
$4,500
Government Insured
500
M-Z
Fund name
Maximum fund amount
Insurance type
Federal poverty level percentage
Macular Degeneration and Related Diseases
$4,600
Government Insured
500
Mantle Cell Lymphoma (MCL)
$5,000
Government Insured
500
Melanoma
$10,000
Government Insured
500
Metabolic dysfunction-associated steatohepatitis (MASH)
$4,200
Government Insured
500
Metastatic Breast Cancer
$7,000
All Insurances
500
Metastatic Colorectal Cancer
$6,000
Government Insured
500
Metastatic Colorectal Cancer Health Equity
$6,000
Government Insured
500
Metastatic Gastric Cancer
$8,000
All Insurances
500
Metastatic Melanoma
$10,000
Government Insured
500
Metastatic Prostate Cancer
$6,000
Government Insured
500
Mucopolysaccharidosis Type III (MPSIII)
$2,500
All Insurances
500
Mucopolysaccharidosis Type VII (MPSVII)
$7,500
All Insurances
500
Mucopolysaccharidosis Type VII (MPSVII) Health Equity
$7,500
All Insurances
500
Multiple Myeloma
$10,000
Government Insured
500
Multiple Myeloma Health Equity
$10,000
Government Insured
500
Multiple Sclerosis (MS)
$8,000
Government Insured
500
Multiple Sclerosis (MS) Health Equity
$8,000
Government Insured
500
Myasthenia Gravis (MG)
$10,000
Government Insured
500
Myelodysplastic Syndromes (MDS)
$8,000
Government Insured
500
Narcolepsy
$5,000
All Insurances
500
Neurofibromatosis (NF)
$6,400
All Insurances
500
Neuromyelitis Optica Spectrum Disorder (NMOSD)
$8,000
All Insurances
500
Neurotrophic Keratitis (NK)
$8,000
Government Insured
500
Neutropenia
$4,400
Government Insured
500
Non-Hodgkin’s Lymphoma (NHL)
$7,200
Government Insured
500
Non-Small Cell Lung Cancer (NSCLC)
$6,000
Government Insured
500
Non-Small Cell Lung Cancer (NSCLC) Health Equity
$6,000
Government Insured
500
Obesity
$2,000
All Insurances
300
Osteoporosis
$2,500
Government Insured
500
Ovarian Cancer
$4,000
Government Insured
500
Ovarian Cancer Health Equity
$4,000
Government Insured
500
Pancreatic Cancer
$6,000
Government Insured
500
Parkinson’s Disease
$4,400
Government Insured
500
Parkinson’s Disease Health Equity
$4,400
Government Insured
500
Paroxysmal Nocturnal Hemoglobinuria (PNH)
$9,500
All Insurances
500
Pemphigus Vulgaris (PV)
$14,600
Government Insured
500
Periodic Paralysis
$1,500
All Insurances
500
Peripheral Vascular and Artery Disease
$1,500
Government Insured
500
Philadelphia Chromosome Negative Myeloproliferative Neoplasms
$9,500
All Insurances
500
Pompe Disease
$9,500
All Insurances
500
Pompe Disease Health Equity
$9,500
All Insurances
500
Primary Biliary Cholangitis (PBC)
$2,500
Government Insured
500
Prostate Cancer
$4,000
Government Insured
500
Prostate Cancer Health Equity
$4,000
Government Insured
500
Psoriasis
$2,500
Government Insured
500
Psoriatic Arthritis
$3,500
Government Insured
500
Pulmonary Fibrosis
$7,000
Government Insured
500
Pulmonary Hypertension
$9,500
All Insurances
500
Renal Cell Carcinoma (RCC)
$8,000
Government Insured
500
Retinal Vein Occlusion (RVO)
$4,600
Government Insured
500
Rett Syndrome (RS)
$4,400
All Insurances
500
Rheumatoid Arthritis
$4,000
Government Insured
500
Schizophrenia
$4,200
Government Insured
500
Short Bowel Syndrome (SBS)
$9,800
All Insurances
500
Sickle Cell Disease
$5,600
Government Insured
500
Skin Cancer
$6,000
Government Insured
500
Small Cell Lung Cancer (SCLC)
$8,500
Government Insured
500
Social Needs Assessment & Intervention
$300
All Insurances
500
Soft Tissue Sarcoma
$5,000
Government Insured
500
Spinal Muscular Atrophy
$6,500
All Insurances
500
Spinal Muscular Atrophy Health Equity
$6,500
All Insurances
500
Stroke
$1,500
Government Insured
500
Thyroid Eye Disease (TED)
$9,000
All Insurances
500
Transportation
$500
All Insurances
500
Type 2 Diabetes (T2DM)
$2,000
Government Insured
500
Type 2 Diabetes (T2DM) Health Equity
$2,000
Government Insured
500
Ulcerative Colitis
$3,000
Government Insured
500
Uterine Cancer
$6,000
Government Insured
500
Uterine Cancer Health Equity
$6,000
Government Insured
500
Uveitis
$1,400
All Insurances
500
Virology Testing Health Equity
$250
All Insurances
500
Von Willebrand Disease (vWD)
$17,600
All Insurances
500
Waldenstrom Macroglobulinemia
$9,500
All Insurances
500
Use our help center to find answers to questions that impact you, so you can make the most informed decisions.
Search help
News
Read the latest news about our merger and programs, access our media kit, and sign up for updates.
Read news
Reach out with any questions or concerns. We will get in touch with you as quickly as possible.